Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma.

[1]  L. Shih,et al.  Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes. , 2010, Leukemia research.

[2]  S. Raimondi,et al.  Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. , 2009, Blood.

[3]  C. Mellink,et al.  Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia. , 2008, Cancer genetics and cytogenetics.

[4]  E. van Binsbergen,et al.  A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review. , 2007, Cancer genetics and cytogenetics.

[5]  M. Teixeira,et al.  SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23) , 2006, Oncogene.

[6]  M. D. Boer,et al.  The MLL recombinome of acute leukemias , 2006, Leukemia.

[7]  Jean McGowan-Jordan,et al.  ISCN 2013 : an international system for human cytogenetic nomenclature (2013) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature , 2005 .

[8]  P. Hall,et al.  Do septins have a role in cancer? , 2005, British Journal of Cancer.

[9]  R. Pieters,et al.  Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Á. Lassaletta,et al.  Chemotherapy-related secondary acute myeloid leukemia in patients diagnosed with osteosarcoma. , 2004, Journal of pediatric hematology/oncology.

[11]  W. Shi,et al.  Second malignant neoplasms in long‐term survivors of osteosarcoma , 2002, Cancer.

[12]  W. Au,et al.  Chromosome 11q deletion in myeloid malignancies , 2002, Leukemia.

[13]  H. Inoue,et al.  Development of Acute Myeloid Leukemia After Chemotherapy for Osteosarcoma , 2001, Clinical orthopaedics and related research.

[14]  L. Trakhtenbrot,et al.  Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization. , 2000, Cancer genetics and cytogenetics.

[15]  N R Schneider,et al.  Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Patchefsky,et al.  Case report 3 , 1976, Skeletal Radiology.

[17]  M. Krzywinski,et al.  New insights to the MLL recombinome of acute leukemias , 2009, Leukemia.

[18]  R. Larson.  Etiology and management of therapy-related myeloid leukemia. , 2007, Hematology. American Society of Hematology. Education Program.

[19]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .